(Q37279001)

19 August 2017

1 reference

title

Molecular alterations associated with bladder cancer initiation and progression (English)

1 reference

19 August 2017

1 reference

Carlos Cordon-Cardo

1

1 reference

PubMed ID

18815930

19 August 2017

language of work or name

1 reference

1 September 2008

1 reference

Scandinavian Journal of Urology and Nephrology. Supplement

19 August 2017

1 reference

19 August 2017

154-165

1 reference

19 August 2017

218

1 reference

Genetic instabilities in human cancers

19 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Cancer genes and the pathways they control

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Somatic mutation of PTEN in bladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

21 January 2018

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

A propensity score approach to estimating the cost-effectiveness of medical therapies from observational data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Squamous cell carcinoma of the bilharzial and non-bilharzial urinary bladder: a review of etiological features, natural history, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Bladder. Risk and prognostic factors--a pathologist's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Localization of the normal allele of T24 human bladder carcinoma oncogene to chromosome 11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Concurrent mutations of coding and regulatory sequences of the Ha-ras gene in urinary bladder carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

PTCH gene mutations in invasive transitional cell carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Structure and methylation-based silencing of a gene (DBCCR1) within a candidate bladder cancer tumor suppressor region at 9q32-q33.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

DBC1 re-expression alters the expression of multiple components of the plasminogen pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Deletions of the INK4A gene in superficial bladder tumors. Association with recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Hyperphosphorylation of pRb: a mechanism for RB tumour suppressor pathway inactivation in bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Amplification and overexpression of E2F3 in human bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Mad2 overexpression promotes aneuploidy and tumorigenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Accumulation of nuclear p53 and tumor progression in bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

p53 gene and protein status: the role of p53 alterations in predicting outcome in patients with bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Genomic and proteomic profiles reveal the association of gelsolin to TP53 status and bladder cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Assessing interactions between mdm-2, p53, and bcl-2 as prognostic variables in muscle-invasive bladder cancer treated with neo-adjuvant chemotherapy followed by locoregional surgical treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

A polymorphism in HDM2 (SNP309) associates with early onset in superficial tumors, TP53 mutations, and poor outcome in invasive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Tumor suppressor role of KiSS-1 in bladder cancer: loss of KiSS-1 expression is associated with bladder cancer progression and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Identifying distinct classes of bladder carcinoma using microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Profiling the evolution of human metastatic bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Bladder cancer outcome and subtype classification by gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

SOX4 expression in bladder carcinoma: clinical aspects and in vitro functional characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Alterations in transcription clusters underlie development of bladder cancer along papillary and nonpapillary pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Gene expression profiling of noninvasive primary urothelial tumours using microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Universal control mechanism regulating onset of M-phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Purification of maturation-promoting factor, an intracellular regulator of early mitotic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Tyrosine phosphorylation of the fission yeast cdc2+ protein kinase regulates entry into mitosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

The Xenopus cdc2 protein is a component of MPF, a cytoplasmic regulator of mitosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Cyclin: a protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Driving the cell cycle: M phase kinase, its partners, and substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

G1 phase progression: cycling on cue

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

21 January 2018

p53: puzzle and paradigm

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

The complexity of p53 modulation: emerging patterns from divergent signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Feedback control of mitosis in budding yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

S. cerevisiae genes required for cell cycle arrest in response to loss of microtubule function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Identification of a human mitotic checkpoint gene: hsMAD2

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

The human homologue of Bub3 is required for kinetochore localization of Bub1 and a Mad3/Bub1-related protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Evolving ideas about cyclins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Cyclin is degraded by the ubiquitin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

CDC20 and CDH1: a family of substrate-specific activators of APC-dependent proteolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Mammalian p55CDC mediates association of the spindle checkpoint protein Mad2 with the cyclosome/anaphase-promoting complex, and is involved in regulating anaphase onset and late mitotic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Mutations of mitotic checkpoint genes in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Characterization of MAD2B and other mitotic spindle checkpoint genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Chromosome missegregation and apoptosis in mice lacking the mitotic checkpoint protein Mad2

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Molecular analyses of the mitotic checkpoint components hsMAD2, hBUB1 and hBUB3 in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

The multiple roles of PTEN in tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Tenets of PTEN tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802291915

10.1080/03008880802291915

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

18815930